{"slideshow_credits": null, "snippet": "Horizon Pharma is a recent entrant on the merger scene, so its low debt load and small size mean it can easily expand. Look for more deals to come.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Robert", "role": "reported", "lastname": "CYRAN", "rank": 1, "organization": ""}], "original": "By ROBERT CYRAN"}, "web_url": "http://www.nytimes.com/2015/07/08/business/dealbook/horizon-pharmas-bid-for-depomed-leaves-room-to-grow.html", "lead_paragraph": "Horizon Pharma is a recent entrant on the merger scene, so its low debt load and small size mean it can easily expand. Look for more deals to come.", "headline": {"main": "Horizon Pharma\u2019s Bid for Depomed Leaves Room to Grow  ", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "_id": "559c266d38f0d81b1af2d3ed", "word_count": "360", "multimedia": [], "pub_date": "2015-07-08T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Horizon Pharma Inc", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "Depomed Inc", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}